Australia announces world-first brain cancer clinical trials

A world-first clinical trial platform launching in Melbourne is set to transform research into new therapies for brain c...

November 1, 2022 | Tuesday | News
“Accelerated ageing is associated with reduced diversification of the gut microbiome that further increases the risk of developing disease”

How would you describe your primary mission and vision of the Centre for Microbiome Medicine?  Microbiome is the l...

November 1, 2022 | Tuesday | Opinion
JW Therapeutics accelerates R&D of T cell-based immunotherapies in China

JW Therapeutics and 2seventy bio have announced a strategic alliance to establish a translational and clinical cell ther...

October 27, 2022 | Thursday | News
NZ brain scientist wins research medal

The winner of this year's pre-eminent research award in the Faculty of Medical and Health Sciences, Professor Michael (M...

October 21, 2022 | Friday | News
Singapore manipulates stress response in cells to help slow down ageing

Nanyang Technological University (NTU) Singapore scientists have found that a stress response in cells, when ‘swit...

October 20, 2022 | Thursday | News
Etana unveils biopharmaceutical factory in Indonesia

PT Etana Biotechnologies Indonesia (Etana) on 7 October, 2022, inaugurated a biopharmaceutical factory located...

October 20, 2022 | Thursday | News
Korea's LG Chem to acquire AVEO Oncology for $566 M

South Korean chemical company LG Chem has announced a definitive agreement with AVEO Oncology in which LG Chem will...

October 20, 2022 | Thursday | News
Singapore identifies new cell population in Alzheimer's disease

An immunity research study has found that the previously identified disease-associated microglia (DAM) population d...

October 17, 2022 | Monday | News
Australia provides $700k to fund new research on women’s fertility

The Australian government is providing almost $700,000 to fund new research investigating the impact of endometriosis on...

October 17, 2022 | Monday | News
Researchers in Korea study new set of biomarkers for diabetes, obesity treatment

According to International Diabetes Federation, approximately 537 million adults (20-79 years) are living with diabetes ...

October 14, 2022 | Friday | News
AdAlta and GPCR Therapeutics collaborate on novel cancer therapeutics

Australia based AdAlta Limited, the clinical stage drug discovery company and South Korea based GPCR Therapeutics Inc, a...

October 13, 2022 | Thursday | News
Hong Kong identifies new therapeutic key to end cancer pain

A new study conducted by The Chinese University of Hong Kong’s (CUHK) Faculty of Medicine (CU Medicine) has discov...

October 13, 2022 | Thursday | News
Singapore discovers non-invasive method to predict relapse of childhood cancers

The most common form of solid tumour affecting children is neuroblastoma. It is known to be the cause of a disproportion...

October 11, 2022 | Tuesday | News
Old drugs offer new ways of treating bowel cancer: NZ study

Old medicines, combined in new ways, are showing promise for treating bowel cancer, a group of University of Auckland re...

October 11, 2022 | Tuesday | News
Australia announces $5.4 M boost for brain cancer research

The Australian Government will invest more than $5.4 million in three groundbreaking brain cancer research projects.&nbs...

October 10, 2022 | Monday | News
Merck Singapore M Lab collaboration center leverages ChromConnect initiative

On October 8, Singapore based Merck’s new M LabTM Collaboration Center brought Singapore's academic groups closer ...

October 8, 2022 | Saturday | News
Education vital to help patients explore gene therapies for blindness: Australian study

Australians with inherited retinal disease (IRD) have a strong interest in undergoing gene therapy to prevent and treat ...

October 7, 2022 | Friday | News
Hong Kong develops novel RNA nanoparticle for atherosclerosis treatment

A team of researchers at The Chinese University of Hong Kong (CUHK) has developed a novel RNA nanoparticle to offer a po...

October 6, 2022 | Thursday | News